Growth Metrics

Bristol Myers Squibb (BMYMP) Other Non-Current Liabilities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $5.0 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 12.84% to $5.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 billion through Dec 2025, up 12.84% year-over-year, with the annual reading at $5.0 billion for FY2025, 12.84% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $5.0 billion at Bristol Myers Squibb, down from $5.5 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $7.7 billion in Q1 2021, with the low at $4.5 billion in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $6.2 billion, with a median of $6.5 billion recorded in 2022.
  • Peak annual rise in Other Non-Current Liabilities hit 15.46% in 2025, while the deepest fall reached 33.5% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $7.3 billion in 2021, then fell by 10.14% to $6.6 billion in 2022, then decreased by 2.56% to $6.4 billion in 2023, then tumbled by 30.4% to $4.5 billion in 2024, then grew by 12.84% to $5.0 billion in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $5.0 billion, $5.5 billion, and $4.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.